Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2018 09:00 ET | Source: Novavax, Inc.

Novavax to Present Clinical Data on RSV F and NanoFlu™ Vaccines at World Vaccine Congress

Update on RSV F Vaccine Phase 3 Prepare™ trial for infants via maternal immunizationResults from Phase 1/2 trial of NanoFlu vaccine demonstrating improved immune responses compared to egg-based,...
March 14, 2018 16:08 ET | Source: Novavax, Inc.

Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results

RSV Phase 3 Prepare™ Trial Outcome De-risked by Successful Informational AnalysisNanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu VaccineJohn J. Trizzino...
March 14, 2018 16:05 ET | Source: Novavax, Inc.

Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer

GAITHERSBURG, Md., March 14, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the promotion of John J. Trizzino to Senior Vice President, Chief Business Officer (CBO) and Chief...
March 07, 2018 16:05 ET | Source: Novavax, Inc.

Novavax to Host Conference Call and Webcast to Provide Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results

GAITHERSBURG, Md., March 07, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will provide a corporate update and report its fourth quarter and full year 2017 financial and...
February 28, 2018 16:05 ET | Source: Novavax, Inc.

Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine

Phase 2 trial of NanoFlu vaccine expected to begin in third quarter of 2018Given strength of trial data, Novavax has submitted detailed results for publication in peer-reviewed medical journal Company...
December 18, 2017 16:32 ET | Source: Novavax, Inc.

Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu™ Vaccine

RSV F Vaccine informational analysis completed in fourth quarter of 2017RSV F Vaccine interim analysis expected mid-2018 with approximately 4,600 enrolleesFiling of RSV F Vaccine BLA anticipated by...
November 08, 2017 16:05 ET | Source: Novavax, Inc.

Novavax to Present at the Stifel 2017 Healthcare Conference

GAITHERSBURG, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Stifel 2017 Healthcare Conference. Presentation details are as...
November 07, 2017 16:05 ET | Source: Novavax, Inc.

Novavax Reports Third Quarter 2017 Financial Results

GAITHERSBURG, Md., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the third quarter and nine months ended September 30, 2017. Third Quarter...
October 31, 2017 16:05 ET | Source: Novavax, Inc.

Novavax to Host Conference Call to Discuss Third Quarter 2017 Financial Results on November 7, 2017

GAITHERSBURG, Md., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter financial and operating results following the close of U.S....
October 13, 2017 07:30 ET | Source: Novavax, Inc.

Novavax Announces Leadership Change

GAITHERSBURG, Md., Oct. 13, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) announced today that Barclay A. “Buck” Phillips has submitted his resignation as Senior Vice President, Chief...